Skip to content

Benchmark Monitor

home
  • Contact Us
  • Education
  • Games
  • Headlines
  • Markets
  • News
  • Movies
  • Trending
  • Contact Us
  • Education
  • Games
  • Headlines
  • Markets
  • News
  • Movies
  • Trending

Tag: Bristol-Myers Squibb Company

Business

Draper signed a tissue model development deal with Bristol-Myers Squibb Company (NYSE:BMY)

Posted onJuly 1, 2019March 7, 2024

Draper, based in Cambridge, Massachusetts, signed a tissue model development deal with Bristol-Myers Squibb Company (NYSE:BMY). The companies will collaborate on developing a unique liver tissue …

Markets

Don’t Miss: American Airlines Group Inc. (NASDAQ:AAL), Bristol-Myers Squibb Company (NYSE:BMY), Geron Corporation (NASDAQ:GERN), WEC Energy Group, Inc. (NYSE:WEC)

Posted onJune 28, 2019June 28, 2019

A U.S. appeals court has ruled that American Airlines Group Inc. (NASDAQ:AAL) was not required to allow a communications specialist with multiple sclerosis to continue …

Business

FDA granted Orphan Drug Designation for Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) lead product

Posted onJune 28, 2019June 28, 2019

Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) said the FDA has granted Orphan Drug Designation for its lead product candidate ARCT-810 to treat ornithine transcarbamylase deficiency – …

Business, Health

Healthcare Mover: Acasti Pharma Inc. (NASDAQ:ACST), Pfizer Inc. (NYSE:PFE), Bristol-Myers Squibb Company (NYSE:BMY)

Posted onJune 27, 2019June 27, 2019

Acasti Pharma Inc. (NASDAQ:ACST) loss for fiscal 2019 expanded from $21.5 million in the prior year to $51.6 million due to higher R&D costs for the TRILOGY Phase …

Business

NIKE, Inc. (NYSE:NKE) releases its new NikeCourt London 2019 collection

Posted onJune 26, 2019June 26, 2019

NIKE, Inc. (NYSE:NKE) releases its new NikeCourt London 2019 collection today, a unique take on traditional tennis whites with a mix of textured piece in both classic while …

Business, Health

Bristol-Myers Squibb Company (NYSE:BMY) provided update on approval process with Celgene Corporation

Posted onJune 25, 2019June 25, 2019

Bristol-Myers Squibb Company (NYSE:BMY) provided an update on the approval process and timeline for the Company’s pending merger with Celgene Corporation. The Company remains actively engaged in …

  • As Market Risks Rise, Firms Like Toronto’s Anson Funds Succeed With Research-Driven Strategies
    In Markets
    July 12, 2025
    In a market defined by macro uncertainty, fragmented […]
  • Building Better Digital Foundations
    In Digital Services
    May 19, 2025
    Technology now sits at the center of how businesses […]
  • Why Remote Control Blinds Are the Future of Smart Homes
    In Home Improvement
    April 23, 2025
    Imagine waking up in the morning, and with a simple […]
  • Children’s Dentistry – Creating Confident Smiles, One Visit at a Time
    In Dental
    April 16, 2025
    At Defiance Dental Old Town, we understand that every […]
  • How to Handle a Dental Emergency: Trust the Best Dentist in Toronto, Ontario
    In Dental
    April 16, 2025
    Dental emergencies can happen at any time, and when […]

AMAZON ASSOCIATES DISCLOSURE

benchmarkmonitor.com Is A Participant In The Amazon Services LLC Associates Program, An Affiliate Advertising Program Designed To Provide A Means For Sites To Earn Advertising Fees By Advertising And Linking To Amazon.Com.

Clicking On An Amazon Link From benchmarkmonitor.com Does Not Increase The Cost Of Any Item You Purchase.

We Will Only Ever Link To Amazon Products That We Think Our Visitors May Be Interested In And Appreciate Learning More About.

© Copyrights 2025 || All Rights Reserved || Powered By benchmarkmonitor.com || Mail Us GeniusUpdates1@Gmail.Com